Prevail Therapeutics

Prevail Therapeutics

World Rank (Aug-2026)
8965
World Rank (Jan-05-2024)
8,965
World Rank (Jul-30-2023)
8,965
World Rank (Jan-07-2022)
8,965
World Rank (Jan-01-2021)
8,965
Market Cap (Jan-01-2021)
0.790 Billion USD
Headquarters Country
USA
World Region
Americas
World Subregion
Northern America
Annual Operating Income in USD
-66 Million USD
Annual Net Income in USD
-63 Million USD
Annual Results for Period Ending
For year ending December-2019
Total Assets in USD
187 Million USD
Total Liabilities in USD
22 Million USD
Total Equity in USD
165 Million USD
Balance Sheet for Period Ending
As of December-2019
Business Sector
Healthcare
Biotechnology
Company Website
PREVAIL THERAPEUTICS
Company Profile
Prevail Therapeutics is a Clinical Stage Biotechnology company seeking to improve lives through the curative potential of gene therapy. The headquarters is in USA.
Founded Year
2017
Stock Exchange
Nasdaq

Share